Quality sourcing with third-party testing remains critical, especially for cagrilintide given limited vendor availability
Frequently asked questions What are the rare side effects of BPC-157
A licensed provider reviews your health history, medications, wellness goals, and eligibility before determining whether peptide therapy may be appropriate
This product is intended solely for laboratory research and is not intended for human consumption, veterinary use, diagnostic procedures, cosmetic use, therapeutic applications, or medical treatment
The closest safety dataset is the Increlex (mecasermin) clinical program , which followed 71 pediatric patients with severe primary IGFD on twice-daily SubQ rhIGF-1 for a mean of 3.9 years (some patients up to 11.5 years)